Pharmacogenetic Targets In Central Nervous System Disorders

Although pharmacotherapy in patients with affective disorders has improved the outcome of millions of patients worldwide, medical treatment of mental depression is efficacious in no more than two-thirds of the cases, and there are no biological markers of treatment response. Apart from identification of genomic markers of treatment response, which would constitute an enormous clinical advantage of public health value, the application of pharmacogenmoics may also uncover new targets for the development of novel and hopefully more efficacious drugs with favorable side-effect profile.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment